Effectiveness of Electromagnetic Field Therapy in Chronic Constipation

NCT ID: NCT06578442

Last Updated: 2025-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-01

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to examine the effects of magnetic field therapy on individuals with chronic constipation. 40 individuals with chronic constipation between the ages of 18-68 who met the inclusion criteria were included in the study. Participants were divided into two groups: treatment group (n=20) and control group (n=2O). The control group was given "constipation coping training" and asked to perform the taught methods every day for 8 weeks. Whether the individuals applied the methods was checked via telehabilitation. Participants in the treatment group received magnetic field therapy twice a week for 8 weeks. Participants were evaluated with the Constipation Severity Scale, Constipation Quality of Life Scale and International Physical Activity Questionnaire before and after the treatment.

Magnetic field therapy provides improvement in sub-parameters such as difficulty in defecation, slowing down of colon movements, and pain due to constipation. It has provided an increase in the quality of life due to constipation. Magnetic field therapy can be applied as an alternative treatment method for the treatment of individuals with chronic constipation problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was carried out in the laboratory of Istanbul Medipol University Physiotherapy and Rehabilitation department on participants between February 2019 and January 2020 and were diagnosed with chronic constipation.

This study was conducted in accordance with the principles of human experimentation specified in the Declaration of Helsinki and with ethics committee approval. Informed consent forms were obtained from the participants.

52 participants were included in our study. The study was completed with 40 participants. Evaluations were made twice, before and after treatment. Magnetic field treatmentwas applied to the participants for 30 minutes a day, twice a week, for 8 weeks, using an electromagnetic field therapy device, in a supine position, by placing circular magnetic field treatment electrodes in the abdominal area, at a power of 25 Hz and 30 Gauss. Participants were informed about the things to consider in magnetic field treatment. To determine the effectiveness of the treatment, evaluations were made before and after the treatment using the Constipation Severity Scale, Constipation Quality of Life Scale, International Physical Activity Questionnaire.

Magnetic field therapy provided improvement in subparameters such as difficulty in defecation, slowing of colon movements, pain due to constipation and increased quality of life due to constipation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation Electrotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups with a conventional therapy
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group

Magnetic Field Treatment was applied to the participants for 30 minutes a day, twice a week for 8 weeks, using an electromagnetic field therapy device, in a supine position, by placing circular magnetotherapy electrodes in the abdominal area, at 25 Hz and 30 Gauss power.

Group Type EXPERIMENTAL

Magnetic Field Treatment

Intervention Type OTHER

Magnetic Field Treatment was applied to the participants for 30 minutes a day, twice a week for 8 weeks, using an electromagnetic field therapy device, in a supine position, by placing circular magnetotherapy electrodes in the abdominal area, at 25 Hz and 30 Gauss power.

Control group

The control group was given "constipation coping training" and asked to perform the taught methods every day for 8 weeks. Whether the individuals applied the methods was checked every day via telerehabilitation.

Group Type EXPERIMENTAL

Constipation Coping Training

Intervention Type OTHER

The control group was given "constipation coping training" and asked to perform the taught methods every day for 8 weeks. Whether the individuals applied the methods was checked every day via telerehabilitation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Field Treatment

Magnetic Field Treatment was applied to the participants for 30 minutes a day, twice a week for 8 weeks, using an electromagnetic field therapy device, in a supine position, by placing circular magnetotherapy electrodes in the abdominal area, at 25 Hz and 30 Gauss power.

Intervention Type OTHER

Constipation Coping Training

The control group was given "constipation coping training" and asked to perform the taught methods every day for 8 weeks. Whether the individuals applied the methods was checked every day via telerehabilitation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of chronic constipation according to Rome III criteria
* Ages of 18-68
* Indicate magnetotherapy treatment,
* Not having used any medication for constipation during the treatment
* Fully cooperative

Exclusion Criteria

* Severely obese patients
* Electrical implants in their body
* First trimester of pregnancy
* Implanted inner ear implants
* Small implants that may be affected by the magnetic field
* Epilepsy
* Untreated hypertoid
* High fever
Minimum Eligible Age

18 Years

Maximum Eligible Age

68 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medipol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dilanur Özkaraoğlu, PT, MSc

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esra Atilgan, PhD

Role: PRINCIPAL_INVESTIGATOR

Medipol University

Gizem Boztas Elverisli, PhD

Role: PRINCIPAL_INVESTIGATOR

Medipol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Medipol University

Istanbul, Beykoz, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MedipolU-FTR-DO-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.